Quality Samples = Quality Results

You are finally ready to start a new experiment with plasma or serum – congratulations! But what kind of data should you be expecting? Your results might surprise you, especially if you work with cellular sample types such as tissue biopsies.

According to the World Health Organization, cancer was the leading cause of death worldwide in 2020 1.

Cell-free DNA (cfDNA) refers to all circulating DNA present in the bloodstream which may originate from apoptotic cells as a part of the natural cell turnover, from cancer cells or fetal cells.

Cell therapy using cardiosphere-derived cells (CDCs) is an increasingly promising treatment for acute and congenital heart muscle injuries, including myocardial infarction (MI).

The National Institute of Health estimates that approximately 6 in 100 000 individuals develop brain or central nervous system-related cancers each year1. Current approaches in the diagnosis of brain cancer include CT scans, MRI and tissue biopsy.

The phrase “natural born leader” is often used to describe those among us with a tendency to dominate, boss, and—put simply—win in life. Newly published research from the Huazhong University of Science and Technology (China) and Boston University (USA) may have demonstrated

A recent study conducted by researchers at the Macquarie University in Sydney, Australia evaluated the efficiency of several commercially available kits for extracting cell-free circulating DNA from plasma samples.